Author:
Chai Yangyang,Wang Guibin,Fan Lili,Zhao Min
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Davis, G. L. et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc. (Bayl. Univ. Med. Cent.). 21, 266–280 (2008).
2. Filmus, J. & Capurro, M. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J. 280, 2471–2476 (2013).
3. Waidely, E., Al-Yuobi, A. R., Bashammakh, A. S., El-Shahawi, M. S. & Leblanc, R. M. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. Analyst. 141, 36–44 (2016).
4. Qian, J. Q., Sun, P., Pan, Z. Y. & Fang, Z. Z. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. Int. J. Clin. Exp. Pathol. 8, 11934–11944 (2015).
5. Ma, S., Yang, J., Li, J. & Song, J. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma. Tumour Biol. doi: 10.1007/s13277-015-4582-9 (2015).
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献